KRMD — Koru Medical Systems Income Statement
0.000.00%
Last trade - 00:00- $129.36m
- $120.37m
- $33.65m
- 77
- 22
- 61
- 53
Annual income statement for Koru Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 24.2 | 23.5 | 27.9 | 28.5 | 33.6 |
| Cost of Revenue | |||||
| Gross Profit | 14.9 | 13.8 | 15.4 | 16.7 | 21.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 25.4 | 30.5 | 38.7 | 38.8 | 40.1 |
| Operating Profit | -1.25 | -7.03 | -10.8 | -10.3 | -6.45 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.19 | -6.36 | -10.7 | -9.77 | -6.06 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.21 | -4.56 | -8.66 | -13.7 | -6.07 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.21 | -4.56 | -8.66 | -13.7 | -6.07 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.21 | -4.56 | -8.66 | -13.7 | -6.07 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.009 | -0.103 | -0.192 | -0.3 | -0.132 |